"Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
Alkaloids
/ pharmacology
Animals
Biological Transport
/ drug effects
Cations
/ pharmacology
Central Nervous System Stimulants
/ pharmacology
Dopamine
/ pharmacology
Dopamine Plasma Membrane Transport Proteins
/ metabolism
HEK293 Cells
Humans
Methamphetamine
/ analogs & derivatives
Organic Cation Transport Proteins
/ drug effects
Substance-Related Disorders
/ drug therapy
Cathinones
Dopamine transporter
Monoamines
Organic cation transporter 3
Psychostimulant
Journal
Neurochemistry international
ISSN: 1872-9754
Titre abrégé: Neurochem Int
Pays: England
ID NLM: 8006959
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
26
07
2018
revised:
14
09
2018
accepted:
19
09
2018
pubmed:
25
9
2018
medline:
27
12
2019
entrez:
25
9
2018
Statut:
ppublish
Résumé
Synthetic cathinone derivatives are a new class of psychoactive substances (NPS), also known as "bath salts", designed to exert psychostimulant effects resembling those of well-known psychostimulants, such as cocaine and 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). As major constituents of bath salts, the cathinone derivatives 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone), have received considerable media attention. MDPV and mephedrone interfere with the function of the high affinity transporters for dopamine (DAT), norepinephrine (NET) and serotonin (SERT), resulting in increased extracellular levels of these monoamines, though their mechanism of action differs. MDPV acts as a non-transported inhibitor of DAT, NET and SERT, whereas mephedrone promotes transporter-mediated release in an amphetamine-like fashion. MDPV and mephedrone are often taken together, creating a conundrum in as much as non-transported inhibitors, like MDPV, prevent mephedrone-induced reverse transport via DAT, NET and SERT. Here we provide evidence supporting a role for organic cation transporter 3 (OCT3) in the actions of mephedrone, which may account for its ability to enhance effects of MDPV. We show that mephedrone can induce substrate efflux via OCT3 in the presence of MDPV. Real-time recordings of the fluorescent OCT3 substrate (4-(4-dimethylamino)styryl)-N-methylpyridinium (ASP
Identifiants
pubmed: 30248432
pii: S0197-0186(18)30343-7
doi: 10.1016/j.neuint.2018.09.008
pii:
doi:
Substances chimiques
Alkaloids
0
Cations
0
Central Nervous System Stimulants
0
Dopamine Plasma Membrane Transport Proteins
0
Organic Cation Transport Proteins
0
Methamphetamine
44RAL3456C
cathinone
540EI4406J
mephedrone
8BA8T27317
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7-12Subventions
Organisme : Austrian Science Fund FWF
ID : W 1232
Pays : Austria
Informations de copyright
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.